Vivos Therapeutics, Inc. Common Stock (VVOS) Stock Price

VVOSStock

$0.13−95.46%52W

Market Cap$4.41M

P/E—

PEG Ratio—

Div yield—

Beta6.44

VVOS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-100.19%

Price vs S&P 500 (4W)-16.79%

VGM Score54.80

Book Value / Share (Quarterly)$0.31

P/TBV (Annual)3.33x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)2.88%

Cash Flow / Share (Quarterly)$-1.31

Price vs S&P 500 (YTD)-105.47%

Gross Margin (TTM)61.90%

Net Profit Margin (TTM)-121.80%

EPS (TTM)$-1.88

10-Day Avg Trading Volume2.75M

EPS Excl Extra (TTM)$-1.88

Revenue Growth (5Y)5.94%

EPS (Annual)$-2.06

ROI (Annual)-140.01%

Gross Margin (Annual)60.44%

Net Profit Margin (5Y Avg)-112.58%

Cash / Share (Quarterly)$0.12

Revenue Growth QoQ (YoY)34.90%

ROA (Last FY)-84.17%

Revenue Growth TTM (YoY)45.21%

EBITD / Share (TTM)$-1.49

ROE (5Y Avg)-818.50%

Operating Margin (TTM)-107.92%

Cash Flow / Share (Annual)$-1.90

P/B Ratio1.72x

P/B Ratio (Quarterly)10.12x

Net Income / Employee (Annual)$-79,000

EV / Revenue (TTM)0.52x

Net Interest Coverage (TTM)-14.16x

ROA (TTM)-101.85%

EPS Incl Extra (Annual)$-2.06

Current Ratio (Annual)0.24x

Quick Ratio (Quarterly)0.16x

3-Month Avg Trading Volume9.44M

52-Week Price Return-95.46%

Revenue / Employee (TTM)$78,000

Tangible BV / Share (Quarterly)$0.04

P/S Ratio (Annual)0.25x

Asset Turnover (Annual)0.69x

52-Week High$3.21

Operating Margin (5Y Avg)-116.51%

EPS Excl Extra (Annual)$-2.06

CapEx CAGR (5Y)81.15%

26-Week Price Return-90.29%

Quick Ratio (Annual)0.20x

13-Week Price Return-68.75%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.21x

Enterprise Value$10.85M

Revenue / Share Growth (5Y)-37.57%

Asset Turnover (TTM)0.84x

Revenue / Employee (Annual)$65,100

Pretax Margin (Annual)-121.71%

Cash / Share (Annual)$0.22

3-Month Return Std Dev101.34%

Gross Margin (5Y Avg)63.50%

Net Income / Employee (TTM)$-95,000

ROE (Last FY)-140.01%

Net Interest Coverage (Annual)-6.45x

EPS Basic Excl Extra (Annual)$-2.06

Receivables Turnover (TTM)13.61x

Total Debt / Equity (Quarterly)3.51x

EPS Incl Extra (TTM)$-1.88

Receivables Turnover (Annual)17.35x

ROI (TTM)-187.51%

P/S Ratio (TTM)0.21x

Pretax Margin (5Y Avg)-112.65%

Revenue / Share (Annual)$1.70

Tangible BV / Share (Annual)$1.29

Price vs S&P 500 (52W)-111.00%

Year-to-Date Return-93.54%

5-Day Price Return-9.08%

EPS Normalized (Annual)$-2.06

ROA (5Y Avg)-103.54%

Net Profit Margin (Annual)-121.37%

Month-to-Date Return-11.36%

Cash Flow / Share (TTM)$-13.48

EBITD / Share (Annual)$-1.81

Operating Margin (Annual)-114.05%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-816.53%

LT Debt / Equity (Quarterly)3.31x

EPS Basic Excl Extra (TTM)$-1.88

P/TBV (Quarterly)71.19x

P/B Ratio (Annual)3.18x

Pretax Margin (TTM)-122.62%

Book Value / Share (Annual)$1.35

Price vs S&P 500 (13W)-71.43%

Beta6.44x

Revenue / Share (TTM)$1.18

ROE (TTM)-351.28%

52-Week Low$0.13

vGradeA

gGradeB

mGradeF

vgmGradeC

VVOS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 14, 2026	-$0.39	-$0.31	+20.51%(+$0.08)
Q1 2026	May 20, 2026	-$0.45	-$0.52	-14.71%(-$0.07)
Q4 2025	Apr 15, 2026	-$0.48	-$0.58	-20.00%(-$0.10)
Q3 2025	Nov 19, 2025	-$0.51	-$0.49	+3.92%(+$0.02)
Q2 2025	Aug 19, 2025	-$0.38	-$0.55	-44.74%(-$0.17)

VVOS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
VVOSVivos Therapeutics, Inc. Common Stock	A	B	F	0.2x	5.9%	61.9%	-107.9%	$0.13
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Vivos Therapeutics, Inc. Common Stock

Vivos Therapeutics develops a non-invasive oral appliance system for treating mild-to-moderate obstructive sleep apnea, combining customized devices with proprietary clinical protocols. The approach offers patients a lower-cost alternative to surgery or pharmaceuticals. The therapy is delivered through a network of specially trained dentists working with medical professionals, creating a differentiated market position in sleep disorder treatment.